Clinical trials: Leishmaniasis, Mucocutaneous
Leishmaniasis, Cutaneous, Leishmaniasis, Mucocutaneous
Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
Patients with biopsy proven new world cutaneous or mucocutaneous leishmaniasis will be treated with sodium stibogluconate (Pentostam).
- Trial name
- NCT00508963
- Testing
- sodium stibogluconate (Pentostam)
- Where
- United States
- Sponsor
- University of California, San Francisco
Cutaneous Leishmaniasis, American
Topical Sm29 in Combination With Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis.
This project is composed of a phase I study with the purpose of evaluating adverse reactions and the best dose to be used of Sm29 and a phase II randomized controlled study with 3 arms with the purpose of comparing the efficacy…
- Trial name
- NCT06000514
- Testing
- Sm29 Protein, Schistosoma Mansoni, Pentavalent antimony (Sbv)
- Where
- Brazil
- Volunteers
- 20 people
- Sponsor
- Hospital Universitário Professor Edgard Santos
Leishmaniasis, Leishmaniasis, Cutaneous
Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis
A clinical trial to asses efficacy and safety of Transition-state Analog Inhibitor of Human Purine Nucleoside Phosphorylase for topical use associated standard antimonial in the treatment of Cutaneous Leishmaniasis in Bahia…
- Conditions
- Leishmaniasis, Leishmaniasis, Cutaneous, Leishmaniasis; American
- Trial name
- NCT03294161
- Testing
- Immucillin DI4G, Meglumine antimoniate
- Where
- Brazil
- Volunteers
- 50 people
- Sponsor
- Hospital Universitário Professor Edgard Santos
Leishmaniasis
Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis
Miltefosine (longer course) will be used to try to improve the cure rate of mucosal leishmaniasis
- Trial name
- NCT00373568
- Testing
- miltefosine: 2.5 mg/kg/day for 42 days
- Where
- Bolivia
- Volunteers
- 25 people
- Sponsor
- AB Foundation